Stockscreener 앱 받기
3.455
1.76%
0.045
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
Number of shareholders of TriSalus Life Sciences, Inc. – NASDAQ:TLSI - TradingView
TriSalus Life Sciences, Inc. (TLSI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating TriSalus Life Sciences, Inc. (TLSI) And Encourages Investors to Connect - ACCESS Newswire
TriSalus Life Sciences, Inc. (TLSI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TriSalus Life Sciences, Inc. (TLSI) Investigation: Bronstein, Gew - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TriSalus Life Sciences, Inc. (TLSI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
TriSalus Life Sciences (TLSI) Falls Over 5% as Stock Tests Key Support Near $3.10Stop Hunt - thelegaladvocate.com
Bronstein, Gewirtz & Grossman, LLC Encourages TriSalus Life Sciences, Inc. (TLSI) Investors to Inquire about Securities Investigation - ACCESS Newswire
TLSI Q1 2026 Earnings: EPS Surprises Positively Despite No Revenue, Stock DeclinesProfit Warning Alert - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating TriSalus Life Sciences, Inc. (RLSI) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating TriSalus Life - The National Law Review
TriSalus Life Sciences (TLSI) Q1 2026 Earnings: EPS Surges Past Expectations, Yet Stock SlipsEBITDA Margin Trends - Newser
TLSI (TLSI) Securities Fraud InvestigationLevi & Korsinsky - Morningstar
Certain Stock Options of TriSalus Life Sciences, Inc. are subject to a Lock-Up Agreement Ending on 22-MAY-2026. - marketscreener.com
Certain Restricted Stock Units of TriSalus Life Sciences, Inc. are subject to a Lock-Up Agreement Ending on 22-MAY-2026. - marketscreener.com
James Pallotta reports 5.2% stake in TriSalus Life Sciences (TLSI) - Stock Titan
38 startups join Innosphere life-sciences incubator - BizWest
Levi & Korsinsky Announces Investigation of Securities Claims Against TLSI (TLSI) - GlobeNewswire
TriSalus (TLSI) CCO reports 543-share tax-withholding sale, retains over 125K shares - Stock Titan
TLSI Investor Alert: Levi & Korsinsky Investigates TLSI (TLSI) for Potential Securities Fraud - Business Wire
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
TriSalus Life Sciences, Inc. Common Stock (TLSI) Stock Price Today & Analysis - Gotrade
TLSI Insider Buying Surge: 5 Executives Purchase $1.3M in Stock - Meyka
TriSalus Life Sciences Director Purchased Shares Worth Over $1.5M - TradingView
TriSalus Life Sciences (TLSI) director buys 10,000 shares in open market - Stock Titan
Director Mats Wahlstrom boosts TriSalus (TLSI) stake with 60,000-share open-market buy - Stock Titan
TriSalus (TLSI) director and LLC add 610K shares in open-market buys - Stock Titan
TriSalus (TLSI) CEO Mary Szela adds 39,682 shares in open-market stock purchase - Stock Titan
TriSalus (TLSI) CFO adds 7,100 shares in open-market purchase - Stock Titan
Earnings call transcript: TriSalus Life Sciences Q1 2026 sees stock gain despite revenue dip By Investing.com - Investing.com Australia
Earnings call transcript: TriSalus Life Sciences Q1 2026 sees stock gain despite revenue dip - Investing.com UK
TLSI SHAREHOLDER INVESTIGATION: SueWallSt Investigates TLSI for Possible Securities Law Violations - PR Newswire
TriSalus Life Sciences Q1 earnings call highlights - MSN
TLSI Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of TLSI (TLSI) - Morningstar
TriSalus Stockholders Back Directors, Auditor and Pay Policies - The Globe and Mail
First Light, Mathew P. Arens disclose 5.37M TLSI shares (TLSI) - Stock Titan
TriSalus (TLSI) grants RSUs and stock options to director Kerry Hicks - Stock Titan
TriSalus (TLSI) director granted RSU and stock option awards - Stock Titan
TriSalus (TLSI) director receives RSU and stock option grants - Stock Titan
TriSalus (TLSI) director Matlin receives RSU and option grants for 2026 service - Stock Titan
TriSalus Life Sciences (TLSI) director granted RSUs and stock options in 2026 award - Stock Titan
TriSalus Life Sciences (TLSI) directors re-elected and pay plan backed in 2026 vote - Stock Titan
TriSalus (TLSI) Q1 2026 Earnings Transcript - AOL.com
TradingKey - TradingKey
Canaccord Genuity Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI) - The Globe and Mail
Nasdaq Surges Over 1%; Alibaba Shares Gain After Q4 Results - Sahm
Dow Falls 200 Points; US Producer Prices Surge In April - Sahm
CCORF Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Lake Street Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
JonesTrading Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Maintains Target Price $11 - Moomoo
TriSalus Life Sciences Bets Big Amid FDA Delay - TipRanks
TriSalus Life Sciences, Inc. Stock 12‑Month Price Target Cut to $8.8, Implies 93% Upside - TradingView
Earnings call transcript: TriSalus Life Sciences Q1 2026 revenue dips amid expansion By Investing.com - Investing.com India
TriSalus Life Sciences, Inc. (TLSI) reports Q1 loss, lags revenue estimates - MSN
TriSalus Life Sciences Q1 Earnings Call Highlights - sharewise.com
TriSalus Life Sciences, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
0.19%
1.33%
자본화:
|
볼륨(24시간):